← SynDRA
SOTULETINIB
SynDRA canonical compound SYN0039340 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | CSF1R |
|---|
| Mechanism of action | CSF1R inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CSF1R INHIBITOR
- CSF3R INHIBITOR
- CSF1R ANTAGONIST
Cross-references
Synonyms
- BLZ945
- BLZ-945
- CSF-1R inhibitor (bone cancer)
- CSF-1R inhibitor (bone cancer), Novartis
- BLZ 945
- 7W3V82OQ0P
- CSF-1R INHIBITOR BLZ945
- RefChem:120669
- UNII-7W3V82OQ0P
- MFCD28142668
- SOTULETINIB [INN]
- KVA-E-23A
- GTPL8250
- orb1301056
- P-BLZ945
- SCHEMBL2676695
- BLZ 945 [WHO-DD]
- SCHEMBL29368442
- SCHEMBL29368661
- EX-A817
- PDS0330
- ADZBMFGQQWPHMJ-RHSMWYFYSA-N
- GLXC-90408
- BDBM50460035
- HB4634
- NSC758006
- s7725
- AKOS025396391
- CCG-268639
- CS-3971
- EBC-220043
- NSC-758006
- NCGC00386432-02
- NCGC00386432-03
- NCGC00386432-05
- NCGC00386432-07
- AC-32994
- AS-16330
- BB178452
Look up SOTULETINIB in the interactive SynDRA portal →